Evidence map›Paper›PMID 33891159›Full record

Observational studyRheumatology international2021

miR-19b-3p and miR-20a-5p are associated with the levels of antiphospholipid antibodies in patients with antiphospholipid syndrome.

Y Juárez-Vicuña, C A Guzmán-Martín, L A Martínez-Martínez, A Hernández-Díazcouder, C Huesca-Gómez, R Gamboa, L M Amezcua-Guerra, M Chacon-Perez, M C Amigo, F Sánchez-Muñoz

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Rheumatology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. The role of monocytes in thrombotic diseases: a review.Frontiers in cardiovascular medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Y Juárez-Vicuña *Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, 14080, Tlalpan, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-6467-6638
C A Guzmán-Martín *Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, 14080, Tlalpan, Mexico City, Mexico.ORCID https://orcid.org/0000-0001-7365-9023
L A Martínez-MartínezDepartment of Rheumatology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID https://orcid.org/0000-0001-7439-2615
A Hernández-DíazcouderDepartment of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, 14080, Tlalpan, Mexico City, Mexico.ORCID https://orcid.org/0000-0001-6569-2851
C Huesca-GómezDepartment of Physiology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-6806-3484
R GamboaDepartment of Physiology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID https://orcid.org/0000-0001-9102-4240
L M Amezcua-GuerraDepartment of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, 14080, Tlalpan, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-6258-5732
M Chacon-PerezPostgraduate Program in Dental and Health Sciences, Universidad Nacional Autónoma de México, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-5596-354X
M C AmigoRheumatology Service, Centro Médico ABC, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-2255-3138
F Sánchez-MuñozDepartment of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, 14080, Tlalpan, Mexico City, Mexico. fausto22@yahoo.com.ORCID https://orcid.org/0000-0001-6556-1632
Instituto Nacional de Cardiología · MXCentro Médico ABC · MXUniversidad Autónoma Metropolitana · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monocytes play a key role in pathophysiology of antiphospholipid syndrome (APS), nevertheless it is unclear if microRNA expression is associated with particular APS features. Identify whether miR-19b-3p and miR-20a-5p expression in monocytes are associated with hallmarks of the APS. Fifty-seven APS patients and 18 healthy controls were studied. Expression of miR-19b-3p and miR-20a-5p was measured in monocytes by RT-qPCR. Both miR-19b-3p (AUC = 0.835, 95% CI 0.733-0.938; P < 0.001) and miR-20a-5p (AUC = 0.857, 0.757-0.957; P < 0.001) discriminated APS patients from healthy individuals. A cut-off point of 1.98 for miR-19-3p and 2.18 for miR-20a-5p showed that APS patients with low microRNA expression had higher levels of IgM and IgG anticardiolipin antibodies than patients with high microRNA expression. In addition, APS patients with low microRNA expression had higher IgG anti-β

Indexed as

AdultAntibodies, AntiphospholipidAntiphospholipid SyndromeCross-Sectional StudiesFemaleHumansMaleMicroRNAsMiddle AgedMonocytesAntibodies, AntiphospholipidMicroRNAsMIRN19A microRNA, humanMIRN20a microRNA, humanAntiphospholipid syndromeMicroRNAMiR-19b-3pMiR-20a-5pMonocytes

Identifiers

PMID33891159
OpenAlexW3153860444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.